AkibaH is launching what it says is the world’s first smartphone case glucometer via the crowdfunding website Indiegogo. Called GluCase, the device is designed to streamline and simplify diabetes management, helping diabetics monitor their sugar levels and share that information directly with their endocrinologist and care team.

The case uses a patent-pending technology that takes all the components of a traditional glucose measuring system, including disposable lancets, test strips and an embedded glucose meter, eliminating the need to carry bulky meters, testing supplies and logbooks.

GluCase uses a patent-pending technology that takes all the components of a traditional glucose measuring system.The companion mobile app communicates with cloud-based physician dashboard to present glucose levels in context of other information such as activity and diet. The information transferred within the platform is encrypted and HIPAA compliant.

“With healthcare becoming more mobile and personalized, we wanted to create something that would work seamlessly in the lives of people with diabetes without impacting the rest of their lifestyle,” says AkibaH founder Fathi Abdelsalam. “Since no one is ever without his or her phone anymore, GluCase solves that problem. We are so excited for our Indiegogo campaign, to show the world what we’ve created to help manage diabetes.”

The Indiegogo campaign will run through December 16, 2015, offering GluCase for $69. At the close of the campaign, AkibaH will finalize product development and pursue FDA 510(k) clearance through official clinical studies. The product is set to ship in September 2016, post-FDA clearance. Also, AkibaH will donate 10% of all proceeds raised by the campaign to the American Diabetes Association, and an additional 2% to the Chris Dudley Basketball Camp for Kids with Diabetes.